Age-adjusted Charlson comorbidity index score is the best predictor for severe clinical outcome in the hospitalized patients with COVID-19 infection: a result from nationwide database of 5,621 Korean patients
View ORCID ProfileDo Hyoung Kim, View ORCID ProfileHayne Cho Park, View ORCID ProfileAjin Cho, View ORCID ProfileJuhee Kim, View ORCID ProfileKyu-sang Yun, View ORCID ProfileJinseog Kim, View ORCID ProfileYoung-Ki Lee
doi: https://doi.org/10.1101/2020.10.26.20220244
Do Hyoung Kim
1Department of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea
2Hallym University Kidney Research Institute, Seoul, Korea
Hayne Cho Park
1Department of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea
2Hallym University Kidney Research Institute, Seoul, Korea
Ajin Cho
1Department of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea
2Hallym University Kidney Research Institute, Seoul, Korea
Juhee Kim
1Department of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea
Kyu-sang Yun
1Department of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea
Jinseog Kim
3Department of Bigdata and Applied Statistics, Dongguk University, Gyeongju, Korea
Young-Ki Lee
1Department of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea
2Hallym University Kidney Research Institute, Seoul, Korea
Article usage
Posted October 27, 2020.
Age-adjusted Charlson comorbidity index score is the best predictor for severe clinical outcome in the hospitalized patients with COVID-19 infection: a result from nationwide database of 5,621 Korean patients
Do Hyoung Kim, Hayne Cho Park, Ajin Cho, Juhee Kim, Kyu-sang Yun, Jinseog Kim, Young-Ki Lee
medRxiv 2020.10.26.20220244; doi: https://doi.org/10.1101/2020.10.26.20220244
Age-adjusted Charlson comorbidity index score is the best predictor for severe clinical outcome in the hospitalized patients with COVID-19 infection: a result from nationwide database of 5,621 Korean patients
Do Hyoung Kim, Hayne Cho Park, Ajin Cho, Juhee Kim, Kyu-sang Yun, Jinseog Kim, Young-Ki Lee
medRxiv 2020.10.26.20220244; doi: https://doi.org/10.1101/2020.10.26.20220244
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (196)
- Cardiovascular Medicine (2877)
- Dermatology (245)
- Emergency Medicine (432)
- Epidemiology (12604)
- Forensic Medicine (10)
- Gastroenterology (811)
- Genetic and Genomic Medicine (4476)
- Geriatric Medicine (407)
- Health Economics (717)
- Health Informatics (2867)
- Health Policy (1057)
- Hematology (378)
- HIV/AIDS (907)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (465)
- Neurology (4233)
- Nursing (226)
- Nutrition (620)
- Oncology (2218)
- Ophthalmology (631)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (489)
- Pediatrics (1182)
- Primary Care Research (485)
- Public and Global Health (6818)
- Radiology and Imaging (1502)
- Respiratory Medicine (907)
- Rheumatology (430)
- Sports Medicine (373)
- Surgery (475)
- Toxicology (59)
- Transplantation (204)
- Urology (175)